Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats
- 14 February 2003
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 461 (2-3), 119-128
- https://doi.org/10.1016/s0014-2999(03)01313-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Single Dose of Monoclonal Anti-Phencyclidine IgG Offers Long-Term Reductions in Phencyclidine Behavioral Effects in RatsJournal of Pharmacology and Experimental Therapeutics, 2002
- Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted AbstinenceJournal of Neuroscience, 2001
- Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine AbusersAmerican Journal of Psychiatry, 2001
- Evidence for long-term neurotoxicity associated with methamphetamine abuseNeurology, 2000
- Pharmacokinetics of Heterologous and Homologous Immunoglobulin G, F(ab‘)2 and Fab after Intravenous Administration in the RatJournal of Pharmacy and Pharmacology, 1997
- Serotonergic functions in arousal and motor activityBehavioural Brain Research, 1995
- Amphetamine: Effects on Catecholamine Systems and BehaviorAnnual Review of Pharmacology and Toxicology, 1993
- Ice: A New Dosage Form of an Old DrugScience, 1990
- Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosisBrain Research Reviews, 1986
- A simple modified carbodiimide method for conjugation of small-molecular-weight compounds to immunoglobulin G with minimal protein crosslinkingAnalytical Biochemistry, 1981